Edition:
United Kingdom

Aurinia Pharmaceuticals Inc (AUPH.OQ)

AUPH.OQ on NASDAQ Stock Exchange Global Market

4.91USD
13 Dec 2017
Change (% chg)

$-0.04 (-0.81%)
Prev Close
$4.95
Open
$4.95
Day's High
$5.03
Day's Low
$4.81
Volume
162,493
Avg. Vol
172,809
52-wk High
$10.54
52-wk Low
$2.03

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Richard Glickman

57 2017 Executive Chairman of the Board, Chief Executive Officer

Dennis Bourgeault

2011 Chief Financial Officer, Corporate Secretary

Michael Martin

2014 Chief Operating Officer

Neil Solomons

2013 Chief Marketing Officer

Celia Economides

2016 Associate Vice President, Corporate Communications & Patient Advocacy